Syntax Research, Inc. Amgen Inc Transaction History
Syntax Research, Inc.
- $131 Billion
- Q1 2024
A detailed history of Syntax Research, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Syntax Research, Inc. holds 237 shares of AMGN stock, worth $73,678. This represents 0.05% of its overall portfolio holdings.
Number of Shares
237
Previous 237
-0.0%
Holding current value
$73,678
Previous $68.3 Million
1.28%
% of portfolio
0.05%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
2,933Shares Held
401MCall Options Held
6.59MPut Options Held
6.6M-
Vanguard Group Inc Valley Forge, PA52.1MShares$16.2 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$14.9 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.06 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.54 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.34 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $166B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...